General MedicationsORALGeneric

TAVIST ALLERGY/SINUS/HEADACHE

ACETAMINOPHEN; CLEMASTINE FUMARATE; PSEUDOEPHEDRINE HYDROCHLORIDE

Standard Dose

500MG;EQ 0.25MG BASE;30MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview TAVIST ALLERGY/SINUS/HEADACHE is listed in Drugs@FDA under application 021082 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CLEMASTINE FUMARATE; PSEUDOEPHEDRINE HYDROCHLORIDE Form and strength TABLET;ORAL - 500MG;EQ 0.25MG BASE;30MG Sponsor NOVARTIS Submission history Latest submission status date: 2002-06-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview TAVIST ALLERGY/SINUS/HEADACHE is listed in Drugs@FDA under application 021082 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAMINOPHEN; CLEMASTINE FUMARATE; PSEUDOEPHEDRINE HYDROCHLORIDE Form and strength TABLET;ORAL - 500MG;EQ 0.25MG BASE;30MG Sponsor NOVARTIS Submission history Latest submission status date: 2002-06-12 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.